These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 3150791

  • 1. Polyamine content in pulmonary arteries from rats with monocrotaline-induced pulmonary hypertension.
    Orlinska U, Olson JW, Gillespie MN.
    Res Commun Chem Pathol Pharmacol; 1988 Nov; 62(2):187-94. PubMed ID: 3150791
    [Abstract] [Full Text] [Related]

  • 2. Polyamine synthesis blockade in monocrotaline-induced pneumotoxicity.
    Olson JW, Orlinska U, Gillespie MN.
    Biochem Pharmacol; 1989 Sep 01; 38(17):2903-10. PubMed ID: 2505777
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Acetylated polyamines in lungs from rats with monocrotaline-induced pneumotoxicity.
    Orlinska U, Olson JW, Gebb SA, Gillespie MN.
    Fundam Appl Toxicol; 1989 Aug 01; 13(2):277-84. PubMed ID: 2507383
    [Abstract] [Full Text] [Related]

  • 7. Altered elastin and collagen synthesis associated with progressive pulmonary hypertension induced by monocrotaline. A biochemical and ultrastructural study.
    Todorovich-Hunter L, Johnson DJ, Ranger P, Keeley FW, Rabinovitch M.
    Lab Invest; 1988 Feb 01; 58(2):184-95. PubMed ID: 3123799
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. 2-Methoxyestradiol mediates the protective effects of estradiol in monocrotaline-induced pulmonary hypertension.
    Tofovic SP, Zhang X, Jackson EK, Dacic S, Petrusevska G.
    Vascul Pharmacol; 2006 Dec 01; 45(6):358-67. PubMed ID: 16872912
    [Abstract] [Full Text] [Related]

  • 10. Altered pulmonary vascular smooth muscle responsiveness in monocrotaline-induced pulmonary hypertension.
    Altiere RJ, Olson JW, Gillespie MN.
    J Pharmacol Exp Ther; 1986 Feb 01; 236(2):390-5. PubMed ID: 3080584
    [Abstract] [Full Text] [Related]

  • 11. CPU0213, a non-selective ETA/ETB receptor antagonist, improves pulmonary arteriolar remodeling of monocrotaline-induced pulmonary hypertension in rats.
    Cui B, Cheng YS, Dai DZ, Li N, Zhang TT, Dai Y.
    Clin Exp Pharmacol Physiol; 2009 Feb 01; 36(2):169-75. PubMed ID: 18986320
    [Abstract] [Full Text] [Related]

  • 12. [Effects of various doses of monocrotaline administration on the development of pulmonary hypertension and its regression in rats].
    Kakusaka I, Kaneko N, Kiyatake K, Fujita A, Suzuki A, Nakano K, Okada O, Sugita T, Watanabe S, Kuriyama T.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Jan 01; 27(1):51-6. PubMed ID: 2501548
    [Abstract] [Full Text] [Related]

  • 13. Genistein, a phytoestrogen, attenuates monocrotaline-induced pulmonary hypertension.
    Homma N, Morio Y, Takahashi H, Yamamoto A, Suzuki T, Sato K, Muramatsu M, Fukuchi Y.
    Respiration; 2006 Jan 01; 73(1):105-12. PubMed ID: 16432296
    [Abstract] [Full Text] [Related]

  • 14. Effect of methylprednisolone on monocrotaline-induced pulmonary vascular disease and right ventricular hypertrophy.
    Langleben D, Reid LM.
    Lab Invest; 1985 Mar 01; 52(3):298-303. PubMed ID: 3156262
    [Abstract] [Full Text] [Related]

  • 15. Upregulation of GLUT-4 in right ventricle of rats with monocrotaline-induced pulmonary hypertension.
    Broderick TL, King TM.
    Med Sci Monit; 2008 Dec 01; 14(12):BR261-4. PubMed ID: 19043358
    [Abstract] [Full Text] [Related]

  • 16. [Lung 3H-thymidine incorporation in monocrotaline (MCT)-treated rats--role of platelet-activating factor (PAF)].
    Ono S, Tanita T, Ashino Y, Noda M, Tabata S, Hoshikawa Y, Ueda S, Nishimura T, Fujimura S.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1994 May 01; 32(5):441-5. PubMed ID: 8084100
    [Abstract] [Full Text] [Related]

  • 17. Mechanisms of lung polyamine accumulation in chronic hypoxic pulmonary hypertension.
    Shiao RT, Kostenbauder HB, Olson JW, Gillespie MN.
    Am J Physiol; 1990 Dec 01; 259(6 Pt 1):L351-8. PubMed ID: 2148056
    [Abstract] [Full Text] [Related]

  • 18. [Effects of prostaglandin E1 (PGE1) on pulmonary hypertension and lung vascular remodeling in a rat monocrotaline model of human pulmonary hypertension].
    Ono S, Tanita T, Hoshikawa Y, Song C, Maeda S, Tabata T, Noda M, Ueda S, Ashino Y, Fujimura S.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Aug 01; 33(8):862-7. PubMed ID: 7474567
    [Abstract] [Full Text] [Related]

  • 19. Pulmonary vasculature in monocrotaline-induced hypertensive rats on magnesium therapy.
    Mathew R, Gloster ES, Altura BT, Altura BM.
    Microcirc Endothelium Lymphatics; 1990 Aug 01; 6(4-5):267-83. PubMed ID: 2149161
    [Abstract] [Full Text] [Related]

  • 20. Effects of endogenous sulfur dioxide on monocrotaline-induced pulmonary hypertension in rats.
    Jin HF, Du SX, Zhao X, Wei HL, Wang YF, Liang YF, Tang CS, Du JB.
    Acta Pharmacol Sin; 2008 Oct 01; 29(10):1157-66. PubMed ID: 18817619
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.